Inventor · disambiguated record
Natale Barbugian
Also filed as: BARBUGIAN NATALE · BARBUGIAN NATALE ALVARO
7 granted patents·3 pending applications·129 citations·filing 1986–2016
85Inventor score
Top patents by PatentIndex Score
10 records- 0193US4808616A6-substituted androsta-1,4-diene-3,17-dionesERBA CARLO SPA·Filed 1986·Granted Feb 28, 1989·71 cites·7 claims
- 0287US4904650ASubstituted androsta-1,4-diene-3,17-dionesERBA CARLO SPA·Filed 1988·Granted Feb 27, 1990·36 cites·8 claims
- 0386US9085565B2Process for the preparation of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamideNERVIANO MEDICAL SCIENCES SRL·Filed 2014·Granted Jul 21, 2015·4 cites·8 claims
- 0484US9382235B2Unsolvated crystalline form 1 of N-[5-(3, 5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide and methods of use thereofNERVIANO MEDICAL SCIENCES SRL·Filed 2015·Granted Jul 5, 2016·3 cites·11 claims
- 0569US4824830A6- or 7-methylenandrosta-1,4-diene-3,17-dione derivatives and process for their preparationERBA CARLO SPA·Filed 1987·Granted Apr 25, 1989·14 cites·8 claims
- 0661US9649306B2Treatment of diseases through administration of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamideNERVIANO MEDICAL SCIENCES SRL·Filed 2016·Granted May 16, 2017·0 cites·10 claims
- 0743US2010069317A1Crystalline nemorubicin hydrochlorideNERVIANO MEDICAL SCIENCES SRL·Filed 2007·Application pending·0 cites
- 0840US2006046993A1Crystalline polymorphic form of irinotecan hydrochloridePHARMACIA ITALIA SPA·Filed 2004·Application pending·0 cites
- 0938US2006281776A1Isotope labeled camptothecin derivativesPFIZER·Filed 2003·Application pending·0 cites
- 1032US5241090AProcess for the preparation of 4-amino-unsaturated androstanedione derivativesERBA CARLO SPA·Filed 1992·Granted Aug 31, 1993·1 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Natale Barbugian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →